Ovid Therapeutics (OVID) Preferred Shares (2016 - 2023)

Ovid Therapeutics has reported Preferred Shares for 7 years, with the latest figure at $1.0 in Q3 2023.

• For the quarter ending Q3 2023, Preferred Shares changed 0.0% year-over-year to $1.0; the trailing twelve-month figure through Sep 2023 stood at $1.0 (changed 0.0% YoY), and the FY2022 full-year result was $1.0, changed 0.0% from the prior year.
• Preferred Shares for Q3 2023 stood at $1.0, roughly flat from $1.0 in the prior quarter.
• The five-year high for Preferred Shares was $8.0 in Q4 2019, with the low at $1.0 in Q1 2021.
• Historically, Preferred Shares has averaged $2.74 across 5 years, with a median of $1.0 in 2021.
• Annual changes were most pronounced in 2020 — Preferred Shares surged 166.67% — and 2021, when it slumped 87.5%.
• Ovid Therapeutics' Preferred Shares stood at $8.0 in 2019, then slumped by 62.5% to $3.0 in 2020, then slumped by 66.67% to $1.0 in 2021, then changed by 0.0% to $1.0 in 2022, then changed by 0.0% to $1.0 in 2023.
• The last three Preferred Shares figures came in at $1.0 (Q3 2023), $1.0 (Q2 2023), and $1.0 (Q1 2023), per Business Quant data.